What's happening
This bill creates a research program to study health risks from potential toxins in feminine hygiene products and requires reporting of findings.
Why it matters
Mandates investigation of a broad range of chemicals. not just dioxins, but also synthetic fibers, chlorine, fragrances, colorants, dyes, preservatives, and contaminants—found in all feminine hygiene products, not just tampons, potentially uncovering previously overlooked health risks.
Focuses on both direct and generational health impacts. requiring research into how these products may affect users’ risks for a wide array of conditions (cancers, immune and reproductive disorders, infections), as well as possible effects on the children of those who used the products before or during pregnancy.
Requires third-party validation of manufacturer claims. by directing state research to confirm data submitted to the FDA by manufacturers, increasing accountability and the chance of catching discrepancies or omissions in industry-reported safety information.
Ensures transparency and public awareness. by mandating that findings, recommendations, and potential policy proposals are shared not only with state leaders but also made publicly accessible, empowering consumers and potentially shaping product standards or regulations.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Study Chemicals in Tampons
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
572
2017-2018 Regular Sessions
IN ASSEMBLY
January 9, 2017
Introduced by M. of A. ROSENTHAL -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to the creation of a research program to determine the risks posed from potential toxins in feminine hygiene products; and providing for the repeal of such provisions upon expiration thereof
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Short title. This act shall be known and may be cited as "the tampon safety and research act".
§ 2. Title 6 of article 2 of the public health law, as added by chapter 342 of the laws of 2014, is amended by adding a new section 267 to read as follows:
§ 267. Tampon safety and research. 1. For purposes of this section, the term "feminine hygiene products" means tampons, pads, liners, cups, sponges, douches, wipes, sprays, and similar products used in conjunction with respect to menstruation or other genital-tract secretions.
2. The commissioner shall provide for the conduct or support of research by the department to determine the extent to which the presence of dioxins, synthetic fibers, chlorine, and other components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in tampons and other feminine hygiene products:
(a) poses any risks to the health of individuals who use the products, including risks relating to cervical cancer, endometriosis, infertility, ovarian cancer, breast cancer, immune system deficiencies, pelvic inflammatory disease, toxic shock syndrome, and bacterial and yeast infections; and
(b) poses any risks to the health of biological children born to individuals who used such products during or before the pregnancies involved, including risks relating to fetal and childhood development.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01938-01-7
A. 572 2
3. Research under subdivision two of this section shall include research to confirm the data on tampons and other feminine hygiene products submitted to the United States food and drug administration by manufacturers of such products.
4. Such research projects shall be completed within four years of the effective date of this section.
5. Within one year of the completion of such research, any conclusions, recommendations and proposals for implementing such recommendations shall be transmitted to the governor, the temporary president of the senate, the speaker of the assembly, the chair of the senate health committee, and the chair of the assembly health committee, and shall also be made available to the public.
§ 3. This act shall take effect on the ninetieth day after it shall have become a law and shall expire and be deemed repealed five years after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.